Welcome to Intracellulartherapies.com - Intra-Cellular Therapies

intracellulartherapies.com

Description: Intra Cellular Therapies. Intra-Cellular Therapies, Inc. (ITI) is a biopharmaceutical company that is developing novel drugs for the treatment of diseases...

Google PR 0

Trustworthiness Good
Avg. Daily Visitors 252

Child Safety Unknown
Avg. Daily Pageviews 505

Privacy Good

Intra-Cellular Therapies

Intracellulartherapies.com: get to the top rated Intra Cellular Therapies pages and content popular with USA-based Intracellulartherapies.com users or check the following digest to find out more. Intracellulartherapies.com is a malware-free website without age restrictions, so you can safely browse it. It seems that Intra Cellular Therapies team are just starting to conquer the social media and they have already achieved a promising result — 45 user activities so far (LinkedIn dominates with around 99% of all user reactions). Intracellulartherapies.com is hosted with CloudFlare, Inc. in United States. Intra Cellular Therapies traffic is estimated at around 7.57K visits per month.

Visit intracellulartherapies.com

Domain info

Location:	United States
Registrant:	PERFECT PRIVACY, LLC
Hosted by:	CloudFlare, Inc.
Registrar:	Register.com, Inc.
Subnetworks:	104.21.1.149, 172.67.129.112

Alexa's Traffic Estimates & Trends

Traffic Rank:	564 066
Month Average Daily Reach:	0.000009	-34.7%
Month Average Daily Pageviews:	0.000001	-64.0%

More details from Alexa

Social Media Activities

Facebook likes: -
Twitter mentions: -
Google pluses: 1
LinkedIn mentions: 44
Pinterest pins: -
StumbleUpon views: -

Web Safety

This website is malware-free.
Status ok

See Google Transparency Report

Sites associated with the same registrant

Whois

Expand

Intracellulartherapies.com popular pages to visit

Home Intra-Cellular Therapies, Inc. (ITI) is a biopharmaceutical company that is developing novel drugs for the treatment of diseases and disorders of the Central Nervous System (CNS). Building on the scie...

Management Team Management Team Sharon Mates, Ph.D. Dr. Mates has been the Chairman of the board of directors, President and Chief Executive Officer of ITI since June 2002. Dr. Mates co-founded ITI in May 2002. Prior...

ITI-007 ITI-007 ITI-007 Our lead product candidate, ITI-007, possesses a mechanism of action targeting multiple brain systems and may allow a physician to fine tune the drug’s action in the brain by sim...